Literature DB >> 8155601

Functional recognition of in vivo processed self antigen.

B Stockinger1, B Hausmann.   

Abstract

C5, the fifth component of complement, is a circulating self protein which induces complete tolerance in MHC class II restricted, CD4+ T cells due to the presentation of C5 taken up from plasma. Functional recognition of in vivo processed C5 was monitored by activation of C5 specific T cell hybrids cultured with antigen presenting cells (APC) from C5 expressing mice. Dendritic cells isolated from various tissues (spleen, thymus, skin) proved to be the most efficient APC, since 10- to 50-fold more macrophages and at least 100- to 500-fold more B cells were needed to achieve similar T cell activation. Stimulatory C5 peptide--class II complexes generated in vivo were retained on the surface of dendritic cells but not on macrophages and B cells upon prolonged culture. Dendritic cells but not macrophages from thymus presented in vivo processed C5. Taken together these findings emphasize the crucial role dendritic cells play for recognition of soluble self proteins by MHC class II restricted T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8155601     DOI: 10.1093/intimm/6.2.247

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  16 in total

1.  Genes predisposing to autoimmunity augment constitutive major histocompatibility complex class II-associated presentation of the self-antigen IgG2a in vivo.

Authors:  K Bartnes; X Li; M Iwamoto; S Izui; K Hannestad
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.

Authors:  Z Dembic; K Schenck; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function.

Authors:  T Zal; S Weiss; A Mellor; B Stockinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

4.  Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells.

Authors:  K Bartnes; K Hannestad
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

5.  Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.

Authors:  T Zal; A Volkmann; B Stockinger
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

6.  T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells.

Authors:  Rosemarie H DeKruyff; Xia Bu; Angela Ballesteros; César Santiago; Yee-Ling E Chim; Hyun-Hee Lee; Piia Karisola; Muriel Pichavant; Gerardo G Kaplan; Dale T Umetsu; Gordon J Freeman; José M Casasnovas
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

7.  Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB.

Authors:  Philippe Stock; Vincent Lombardi; Viola Kohlrautz; Omid Akbari
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection.

Authors:  Jason Perera; Liping Meng; Fanyong Meng; Haochu Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

9.  ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.

Authors:  Omid Akbari; Philippe Stock; Everett H Meyer; Gordon J Freeman; Arlene H Sharpe; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.

Authors:  O Akbari; P Stock; A K Singh; V Lombardi; W-L Lee; G J Freeman; A H Sharpe; D T Umetsu; R H Dekruyff
Journal:  Mucosal Immunol       Date:  2009-09-09       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.